SCD Antibody

說明書

中文名稱：

SCD兔多克隆抗體
貨號：

CSB-PA170230
規(guī)格：

￥1100
圖片：
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA170230(SCD Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)

The image on the left is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using CSB-PA170230(SCD Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)

Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: 293T cells, lovo cells, Primary antibody: CSB-PA170230(SCD Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關產(chǎn)品
靶點詳情

產(chǎn)品詳情

Uniprot No.：

O00767
基因名：

SCD
別名：

SCD; FADS5; SCD1; SCDOS; Stearoyl-CoA desaturase; hSCD1; Acyl-CoA desaturase; Delta(9-desaturase; Delta-9 desaturase; Fatty acid desaturase
宿主：

Rabbit
反應種屬：

Human
免疫原：

Synthetic peptide of Human SCD
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
抗體亞型：

IgG
純化方式：

Antigen affinity purification
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
產(chǎn)品提供形式：

Liquid
應用范圍：

ELISA,WB,IHC

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:1000-1:2000
WB	1:200-1:1000
IHC	1:10-1:50

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Stearoyl-CoA desaturase that utilizes O(2) and electrons from reduced cytochrome b5 to introduce the first double bond into saturated fatty acyl-CoA substrates. Catalyzes the insertion of a cis double bond at the delta-9 position into fatty acyl-CoA substrates including palmitoyl-CoA and stearoyl-CoA. Gives rise to a mixture of 16:1 and 18:1 unsaturated fatty acids. Plays an important role in lipid biosynthesis. Plays an important role in regulating the expression of genes that are involved in lipogenesis and in regulating mitochondrial fatty acid oxidation. Plays an important role in body energy homeostasis. Contributes to the biosynthesis of membrane phospholipids, cholesterol esters and triglycerides.
基因功能參考文獻：
1. Study results suggest that stearoyl-coenzyme A desaturase 1 activity is required for cumulus cell lipid storage and steroidogenesis. PMID: 28345489
2. study has provided evidence supporting the potential role of SCD1 as a biomarker for human bladder cancer prognosis. PMID: 29396722
3. SCD1 overexpression was found in Hepatocellular Carcinomas , which was associated with shorter disease-free survival. PMID: 28647567
4. Experimental models in mice and human epithelial cells suggest that inhibition of stearoyl-coenzyme A desaturase activity leads to airway hyper-responsiveness and reduced antiviral defense. PMID: 28397284
5. alterations in leptin and SCD-1 in HCU patients PMID: 28801090
6. CD36, also known as FA translocase (FAT), that functions as a transmembrane protein and mediates the uptake of FAs, is observed to be highly expressed in breast cancer tissues. Furthermore, the anti-proliferation effect caused by the SCD1 inhibitor can not be reversed by exogenous oleic acid supplementation in CD36 knockdown breast cancer cells PMID: 28765876
7. Our findings suggested that SCD1 plays a key role in the pathophysiology of leptin resistance in neuronal cells associated with obesity. PMID: 28768997
8. high expression of SCD1 is more frequently observed in late stage lung adenocarcinoma patients and presents poor prognosis PMID: 27223066
9. Our results suggest that relatively common genetic variants in stearoyl CoA desaturase and SREBF1 attenuated the positive associations between intake of a traditional diet rich in n-3 polyunsaturated fatty acids and increases in fasting cholesterol and HbA1c levels, as well as the waist-to-hip ratio among Yup'ik participants. PMID: 27467133
10. Results provide evidence that SCD is a regulator of breast stemness. PMID: 27306423
11. these data demonstrate for the first time the involvement of SCD1 in the regulation of the Hippo pathway in lung cancer, and point to fatty acids metabolism as a key regulator of lung cancer stem cells. PMID: 28368399
12. High SCD1 expression is associated with resistance to cisplatin in lung cancer. PMID: 28797843
13. Results provide evidence that the hepatic BSCL2 deficiency induces the increase and expansion of lipid droplets potentially via increased SCD1 activity. PMID: 27838812
14. high SCD1 expression is an independent prognostic factor for OS in patients with ccRCC. Our data suggest that the expression of SCD1 might guide the clinical decisions for patients with ccRCC. PMID: 27861513
15. A relevant link between one-night sleep deprivation , hepatic SCD1 expression and de-novo fatty acid synthesis via epigenetically driven regulatory mechanisms was found. PMID: 27562731
16. stearoyl-coenzyme A desaturase 1 has a role in clear cell renal cell carcinoma PMID: 26224474
17. Chronic exposure to chewing tobacco induces carcinogenesis in non-malignant oral epithelial cells and SCD plays an essential role in this process. PMID: 26391970
18. This study illustrates for the first time that, in contrast to hepatic and adipose tissue, estrogen induces SCD-1 expression and activity in breast carcinoma cells. These results support SCD-1 as a therapeutic target in estrogen-sensitive breast cancer. PMID: 26022099
19. The data indicate a direct inhibitory interaction of polyunsaturated fatty acids with LXRalpha, a consequent reduction of SREBP-1 and of its binding to SCD1 promoter. PMID: 25264165
20. Both siRNA-mediated and pharmacological inhibition of SCD1 impaired tumor cells migration. PMID: 25880005
21. SCD1 is found upregulated upon renal cell transformation indicating that its activity, while not impacting proliferation, represents a critical bottleneck for tumourigenesis PMID: 24769897
22. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway. PMID: 25528629
23. An association with Graves ophthalmopathy was shown for SNP rs1393491 in SCD. PMID: 24780075
24. Stearoyl-CoA desaturase is encoded by an SCD gene, which, depending on the species, may exist as different isoforms. (review) PMID: 24864084
25. DNA methylation levels of the SCD1 promoter were associated with weight change and with adherence to a Mediterranean diet. PMID: 24827925
26. These data further support the idea that SCD1 is associated with hepatitis C virus replication complex and that its products may contribute to the proper formation and maintenance of membranous web structures during virus replication. PMID: 25122791
27. These results demonstrate that cardiometabolic risk factors are modulated by genetic variations in the SCD1 gene alone or in combination with n-3 polyunsaturated fatty acid supplementation. PMID: 24375980
28. Genetic variation of the SCD1 gene may contribute to the risk of obesity, interacting with the type of dietary fat. PMID: 23934750
29. The effect of fenretinide on stearoyl-CoA desaturase should be considered in its potential therapeutic role against cancer, type-2 diabetes, and retinal diseases. PMID: 24357007
30. The results suggest that SCD1 is a critical target in lung cancer tumor-initiating cells. PMID: 24309934
31. genetic association studies in population of men in Sweden: Data suggest that SNPs in SCD1 are associated with cancer death, especially among men with low intake of dietary polyunsaturated fatty acids. PMID: 24368438
32. This minireview summarizes the role of skin SCD1 in regulating skin integrity and whole body energy homeostasis and offers a discussion of potential pathways that may connect these seemingly disparate phenotypes. PMID: 24356954
33. SCD was strongly expressed in surgically resected hepatocellular carcinoma (HCC) (n = 64) and various human HCC cell lines PMID: 24135379
34. Human breast cancer tissues contain abundant phosphatidylcholine(36ratio1) with high stearoyl-CoA desaturase-1 expression. PMID: 23613812
35. Increased SCD1 expression supports clear cell renal cell carcinoma cell viability. PMID: 23633458
36. Patients with primary breast cancers expressing high SCD1 levels had significantly shorter relapse-free survival and overall survival in multivariable analysis. PMID: 23208590
37. Both SCD1 and HIF-2alpha are critical to promoting tumorigenesis by synergistically acting on maintaining cell survival, triggering cell migration, and enhancing the colony formation ability of ca PMID: 23331615
38. In a large community-based prospective cohort study, the estimate of SCD-1 activity by SCD16c had the strongest association with incident diabetes. PMID: 22819528
39. There are no associations between common variants of SCD1 or its inferred haplotypes and the investigated metabolic risk factors. PMID: 23139775
40. In human bladder cancer cell lines expressing constitutively active FGFR3, knockdown of SCD1 by siRNA markedly attenuated cell-cycle progression, reduced proliferation, and induced apoptosis. PMID: 23019225
41. findings show low SCD1 expression is linked to a decrease in proliferation rate of breast cancer cells; this was accompanied by an increase in GSK3 activity; nuclear translocation of beta-catenin was decreased and its transactivation capacity; this suggests a role of SCD1 in EMT and cancer progression PMID: 23013158
42. Thyroid hormone negatively regulates human SCD-1 gene expression in without direct binding of the TH receptor to the SCD-1 gene promoter. PMID: 23221600
43. The individual hepatic SCD1 activity is a determinant of liver fat accumulation under lipogenic dietary conditions. PMID: 23015656
44. data indicate that SCD activity may control lung cancer cell metabolism, proliferation and survival by modulating the EGFR-->Akt/ERK signaling platforms PMID: 22946088
45. study showed cystic fibrosis cells exhibit increased metabolism along metabolic pathways leading to n-7 and n-9 fatty acids compared with wild-type cells; changes are accompanied by increased expression of Delta5, Delta6 and Delta9 desaturases and elongases 5 and 6 PMID: 21544602
46. The mRNA levels of LXRalpha and SREBP-1c, transcription factors that regulate SCD-1, were decreased by 10,12 conjugated linoleic acid in human adipocytes. PMID: 21775116
47. data outline an effective strategy to establish an unambiguous link between fatty acid synthesis and cancer cell survival, and point toward SCD1 as a key target in this pathway PMID: 22457791
48. SCD1 activity and genetic variation have an important role in modulating the relationship between fatty acids and inflammation in young adults PMID: 22209225
49. Repression of SCD1 by alpha-linolenic acid favorably increased cholesterol efflux and decreased cholesterol accumulation in foam cells. PMID: 21658928
50. [review] muscle. This review evaluates the role of SCD-1 as a homeostatic check-point between glucose and fatty acid metabolism in the development and progression of obesity. PMID: 21831035
顯示更多

收起更多
亞細胞定位：

Endoplasmic reticulum membrane; Multi-pass membrane protein.
蛋白家族：

Fatty acid desaturase type 1 family
組織特異性：

Detected in fetal liver, lung and brain. Highly expressed in adult adipose tissue, and at lower levels in adult brain and lung.
數(shù)據(jù)庫鏈接：

HGNC: 10571

OMIM: 604031

KEGG: hsa:6319

STRING: 9606.ENSP00000359380

UniGene: Hs.558396

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human